Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes
Copyright © 2020. Published by Elsevier B.V..
Isolation of the new pandemic virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for diagnostic and research purposes including assessment of novel therapeutics. Several primary and continuous cell lines are currently used, and new organoid and engineered cell lines are being developed for improved investigation and understanding of the human immune response to this virus. Here we review the growth of SARS-CoV-2 in reference standard cell lines, engineered cell lines and new developments in this field.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
|---|---|
| Enthalten in: |
Pathology - 52(2020), 7 vom: 29. Dez., Seite 760-763 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Stelzer-Braid, Sacha [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cell culture |
|---|
| Anmerkungen: |
Date Completed 04.12.2020 Date Revised 22.05.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.pathol.2020.09.012 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317002104 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317002104 | ||
| 003 | DE-627 | ||
| 005 | 20231225162318.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.pathol.2020.09.012 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1056.xml |
| 035 | |a (DE-627)NLM317002104 | ||
| 035 | |a (NLM)33131800 | ||
| 035 | |a (PII)S0031-3025(20)30939-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Stelzer-Braid, Sacha |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.12.2020 | ||
| 500 | |a Date Revised 22.05.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020. Published by Elsevier B.V. | ||
| 520 | |a Isolation of the new pandemic virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for diagnostic and research purposes including assessment of novel therapeutics. Several primary and continuous cell lines are currently used, and new organoid and engineered cell lines are being developed for improved investigation and understanding of the human immune response to this virus. Here we review the growth of SARS-CoV-2 in reference standard cell lines, engineered cell lines and new developments in this field | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Severe acute respiratory syndrome coronavirus 2 | |
| 650 | 4 | |a cell culture | |
| 650 | 4 | |a respiratory virus | |
| 650 | 4 | |a virus culture | |
| 700 | 1 | |a Walker, Gregory J |e verfasserin |4 aut | |
| 700 | 1 | |a Aggarwal, Anupriya |e verfasserin |4 aut | |
| 700 | 1 | |a Isaacs, Sonia R |e verfasserin |4 aut | |
| 700 | 1 | |a Yeang, Malinna |e verfasserin |4 aut | |
| 700 | 1 | |a Naing, Zin |e verfasserin |4 aut | |
| 700 | 1 | |a Ospina Stella, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Turville, Stuart G |e verfasserin |4 aut | |
| 700 | 1 | |a Rawlinson, William D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pathology |d 1969 |g 52(2020), 7 vom: 29. Dez., Seite 760-763 |w (DE-627)NLM000008656 |x 1465-3931 |7 nnns |
| 773 | 1 | 8 | |g volume:52 |g year:2020 |g number:7 |g day:29 |g month:12 |g pages:760-763 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.pathol.2020.09.012 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 52 |j 2020 |e 7 |b 29 |c 12 |h 760-763 | ||